71703-26-9

Upstream product

• 108-24-7 acetic anhydride 
• 142066-41-9 2-(chloromethyl)-phenyl methanol 
• 612-12-4 o-Xylylene dichloride 
• 496-14-0 1,3-dihydroisobenzofuran 
• 75-36-5 acetyl chloride 
• 612-14-6 phthalyl alcohol 

Downstream Products

• 71742-83-1 2-Allyl-2-(2-hydroxymethyl-benzyl)-5,5-dimethyl-cyclohexane-1,3-dione 
• 71703-30-5 2-Benzyl-2-(2-hydroxymethyl-benzyl)-5,5-dimethyl-cyclohexane-1,3-dione 
• 1173021-41-4 2-[(diethoxyphosphoryl)methyl]benzyl acetate 
• 71703-34-9 Acetic acid 2-(1,4,4-trimethyl-2,6-dioxo-cyclohexylmethyl)-benzyl ester 
• 71703-32-7 2-(2-Hydroxymethyl-benzyl)-2,5,5-trimethyl-cyclohexane-1,3-dione 

Relevant academic research and scientific papers

Syntheses of 5-chlorouracils/thymines with 1-[phosphono(methyl/ difluoromethyl)]-1,2-unsaturated-moiety-substituted methyl groups at N(1) and human thymidine phosphorylase inhibitory activity

By attaching (methyl)- or (difluoromethyl)-phosphonate groups to the 1-positions of ethene, cyclopentene or benzene, and attaching 1-(methyl)-5-chlorouracil or 1-(methyl)thymine groups to the corresponding 2-positions, compounds 1 - 5 were prepared as pot

Method for manufacturing 3-isochromanone

The present invention intends to provide a method for producing 3-isochromanones represented by formula (II) useful as a synthetic starting material of medicals or agricultural chemicals and the cyano compound represented by formula (I) by an industrially advantageous method in a high yield.Disclosed herein is a method for manufacturing a 3-isochromanone represented by the following formula (II): (wherein R2, R3, R4 and R5 each independently represents a hydrogen atom, a halogen atom, an alkyl group or an alkoxy group),said method is characterized by comprising the steps of:hydrolyzing a cyano compound represented by formula (I): (wherein R1 represents a hydrogen atom, an alkyl group or an aryl group, and R2, R3, R4 and R5 have the same meanings as defined above) and subjecting the hydrolyzate to intra-molecular cyclization.

Imidazopyridine compounds and processes for preparation thereof

The invention relates to an imidazopyridine compound of the formula: STR1 wherein R1 is lower alkynyl, lower alkynyloxy(lower)alkyl or N,N-di(lower)alkylamino(lower)alkynyl, R2 is lower alkyl, R3 is mono (or di or tri)-phenyl(lower)alkyl substituted by one or more substituent(s) selected from cyano, carbamoyl, mono (or di or tri(phenyl(lower)alkylamino, acylamino, carboxy, esterified carboxy, hydroxy, hydroxy(lower)alkyl, acyloxy(lower)alkyl, acyloxy, mono (or di or tri)phenyl(lower)alkoxy, lower alkoxy(lower)alkoxy, tetrahydropyranyloxy, and acylamino(lower)alkyl or mono (or di or tri) phenyl(lower)alkyl substituted by lower alkyl and one additional substituent selected from hydroxy(lower)alkyl, amino, N-lower alkyl-N-acylamino, mono (or di or tri)phenyl(lower)alkylamino, acylamino and lower alkylamino, and R4 is hydrogen or lower alkyl, and a pharmaceutically acceptable salt thereof, useful in the treatment of ulcers.